Remove 2013 Remove Clinical Trials Remove Conditions Remove Treatment
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. In 2013, section C and J of Canada’s FDR statute were amended so that “restricted drugs” were inaccessible through SAP.

Therapy 52
article thumbnail

DMT Therapy: Coming to a Clinic Near You?

Canna Law Blog

Notwithstanding its dubious distinction as a Schedule I drug, DMT increasingly is the subject of study for its potential efficacy in treating a wide array of mental-health conditions including depression, anxiety, and PTSD. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction.

Therapy 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Realm of Caring Appoints Research Director to Oversee Groundbreaking Cannabis Data Registry and Medical Studies

Cannabis Law Report

The results affirm what has been suspected for a long time, that cannabinoid products have value in the treatment of epilepsy as well as associated neuropsychiatric conditions,” said Jay Salpekar, MD, an Associate Professor of Psychiatry and Neurology at Johns Hopkins University. “It About Realm of Caring. Lindsey Clarke.

Data 105
article thumbnail

Cannabis and OCD: Seeking Relief

PrestoDoctor

Obsessive-Compulsive Disorder (OCD) is a debilitating mental health condition that is characterized by intrusive thoughts and compulsive behaviors. While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. These obsessions can vary greatly from person to person.

article thumbnail

Canada: First patient in Quebec gets approval for magic mushroom therapy

Cannabis Law Report

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52
article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. For the regulated community, this is a trend worth watching. Approval Pathways.

article thumbnail

Best strains and terpenes for pain management

The Cannigma

Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. 12 Pinene had the ability to meditate chemical responses to inflammation in rodent trials.

Terpenes 111